The mechanisms underlying the resolution of hepatitis B virus (HBV) infection remain undetermined. Tumor necrosis factor-α (TNF-α) plays a pivotal role in host immune response to HBV, and the capacity for cytokine production in individuals has a major genetic component. The aim of this study was to examine whether TNF-α promotor polymorphisms are associated with the clearance of HBV infection. A total of 1,400 Korean subjects were enrolled in 2 different groups: "chronic carrier group" (CC; n=1,109), who were repeatedly hepatitis B surface antigen (HBsAg)-positive, and "subjects who spontaneously recovered" (SR; n=291), who were HBsAg-negative with antibodies to HBsAg and hepatitis B core antigen. TNF-α promoter polymorphisms at positions
INTRODUCTION
Hepatitis B virus (HBV) infection is a global public health problem, as HBV infects more than 350 million people worldwide (1) . The clinical course of HBV infection varies from spontaneous recovery after acute hepatitis to a chronic persistent infection that may progress to cirrhosis or hepatocellular carcinoma. The mechanisms underlying resolution of acute HBV infection or its progression to chronicity remain undetermined.
Age at infection has the most significant impact on the clinical outcome, evidenced by the fact that chronic infection occurs in approximately 90% of infants infected at birth, in 25 to 50% of children infected between the ages of 1 and 5 years, and in less than 5% of those infected during adult life (2) (3) (4) . It is well known that the major mode of infection in HBV-endemic areas, including Korea, is perinatal transmission (2, 5) . The mechanisms underlying resolution of acute HBV infection or its progression to chronicity at each age group remain undetermined. When determining the chronicity of HBV infection within a group of patients who are presumed to have been infected at the same age, i.e., perinatally, in Korea, it is apparent that the outcome of the infection does not appear to be determined by variations in virulence of the viral strains (6, 7) , but that host factors are likely to influence disease outcome (8, 9). Thus, it is conceivable that genetic differences play an additional role.
Cell-mediated immune responses directed toward infected liver cells have been considered to be the main inducer of hepatic injury and mediators of HBV clearance (8, 10). On the other hand, recent evidence also suggests that antiviral cytokines, such as tumor necrosis factor-α (TNF-α) and interferon gamma, released by the activated effector cells of innate and adoptive immune systems in the region of their targets, can induce the noncytolytic suppression of HBV expression and replication in the liver (11-13). TNF-α inhibits the transcriptional activity of the HBV core promoter in vitro (14).
In an HBV transgenic mouse model and acutely infected chimpanzees, only a minority of infected hepatocytes were eliminated by direct contact with cytotoxic T cells (12, 13).
In the vast majority of infected cells, HBV appears to be suppressed and eliminated by antigen-non-specific cytokines (12, 13).
The capacity for cytokine production in an individual has a major genetic component, and striking differences exist among individuals in terms of their ability to produce cytokines, which have been ascribed to polymorphisms within the regulatory regions or signal sequences of cytokine genes (15). Several biallelic polymorphisms have been described within the TNF-α gene, including seven in the promoter region at positions -1031T>C, -863C>A, -857C>T, -376G>A, -308G>A, -238G>A, and -163G>A base pairs from the transcription start site (16, 17). Moreover, a number of
RESULTS
The genotype distribution of TNF-α promoter polymorphisms at the positions -1031T>C, -863C>A, -857C>T, -376G>A, -308G>A, -238G>A, and -163G>A were not significantly different between the healthy unrelated control and study groups (data not shown). The genotype frequencies of the "chronic HBV carriers" (CC) and "the subjects who spontaneously recovered" (SR) groups for each polymorphism of TNF-α are showed in Table 1 . No evidence of a departure from the Hardy-Weinberg equilibrium was apparent. The frequencies of minor alleles of the TNF-α promoter polymorphisms at positions -1031T>C, -863C>A, -857C>T, -376G>A, -308G>A, -238G>A, and -163G>A were 0.14, 0.18, 0.15, 0.001, 0.04, 0.06, and 0.02, respectively (n = 1,400).
The frequency of TNF-α-376G>A was extremely rare in the Korean population and was excluded from further analysis. Fourteen haplotypes were identified among the single nucleotide polymorphisms (SNPs) (Fig. 1B) . In the initial analysis, a significant increase of homozygous and heterozygous individuals for the TNF-α-863A allele (TNF-α-863A/C or A/A) was observed in the CC group than the SR group (OR=1,52-1.58, P=0.003-0.004; Table 1 ). In contrast, the -308A allele (TNF-α-308A/G or A/A) was significantly associated with HBV clearance and protective antibody production (OR=0.56-0.57, P=0.01; Table 1 ). All other loci showed no significant associations. Among 14 haplotypes, three common haplotypes with frequency greater than 5% were used for analysis (Fig. 1B) We further evaluated whether TNF-α-863C>A or -308G>A polymorphisms are associated with HLA-DRB1*13, which has been linked with protection against chronic HBV infection (7, 20, 21). HLA-DR13 was only associated with TNF-α-308A in the 107 healthy unrelated Korean subjects ( Table 2) . Significantly associated HLA alleles with TNF-α haplotypes in Korean populations are shown in Table 2 . TNF-α haplotypes 1, 2 and 3 were not associated with HLA-DR13.
Discussion
In the present study, the TNF-α promoter allele associated with higher-plasma TNF- The present study demonstrates that the resolution of HBV infection is associated with TNF-α promoter alleles, which were reported to be related with higher circulating levels of TNF-α, and thus, suggests the importance of TNF-α promoter polymorphisms in the noncytolytic clearance of HBV in addition to cytolytic clearance.
In a former study, an association was found between the TNF-α-238A promoter variant and chronic HBV infection, but no such association was found for the variant at position -308 (23). However, in the present study, chronic HBV infection was not associated with the TNF-α-238A allele, but rather, spontaneous HBV clearance was found to be associated with the TNF-α-308A allele. The exact cause of this contradiction is unknown. However, differences in the mode of viral transmission (perinatal vs. horizontal in adulthood) and ethnic difference between Asians and Caucasians might be involved. In addition, the number of ~200 subjects enrolled in the previous work, involving statistical analysis corrected for small numbers might not have been adequate for an association study.
Undoubtedly, it is possible that the associations we observed are caused by other confounding genetic or environmental factors. An inappropriate viral antigen presentation to T-lymphocytes, controlled by the MHC gene, may induce persistent HBV infection. Indeed, other groups have identified that DRB1*13 has a protective effect against the development of chronic hepatitis B in Africans, Caucasians, and Koreans (7, 20, 21) . Moreover, the exact mechanism of an association between individuals carrying HLA-DRB1*13 and HBV clearance is unclear. The beneficial effect of the HLA-DRB1*13 allele on the outcome of HBV infection may be the result of more proficient antigen presentation by HLA-DRB1*13 molecules themselves, or of a linked polymorphism in a neighboring immunoregulatory gene, such as a TNF-α promoter gene. We showed that TNF-α-863C, which was associated with HBV clearance in the present study, is not in linkage disequilibrium with HLA-DRB1*13 in Koreans. Therefore, the protective effects of TNF-α-863C against HBV are not caused by HLA-DRB1*13 in Koreans and vice versa. TNF-α haplotypes 1 and 2 were found not to be associated with HLA-DRB1*13 either. On the other hand, the TNF-α-308A variant was found to be in strong linkage disequilibrium with HLA-DRB1*13 in this study. Therefore, it is not clear which genetic factor, HLA-DRB1*13 or TNF-α -308A, is primarily associated with the protective effect against HBV. It is also possible that the TNF-α promoter polymorphisms and HLA-DRB1*13 are independent factors encoded within the MHC that influence HBV infection outcome, as another group of researchers has suggested (23). To solve this question, a functional and quantitative study capable of defining the respective effects of the TNF-α polymorphism and HLA-DRB1*13 should be carried out.
The allele frequencies of TNF-α promoter polymorphisms -863A and -308A were 0.18 and 0.04 in the present study, respectively. In healthy Swedish men, Swedish women, and Japanese,. the allele frequencies of -863A were 0.17, 0.14, and 0.14 (16, 22, 24), respectively, and in Taiwanese, Swedes, Gambians, Caucasians in the USA, and in Japanese, the frequencies of -308A were 0.14, 0.20, 0.16, 0.14, and 0.017, respectively (16, 22, (25) (26) (27) . Thus, the TNF-α-308G>A polymorphism is relatively rare in Koreans and Japanese. Therefore, it might be anticipated that -863C>A would play a more dominant role in determining the natural course of HBV infection than the -308G>A polymorphism in the Korean population. Accordingly, most of the Korean haplotypes contained the -308G allele and not the -308A allele, and the outcome of HBV infection seemed to be determined by the presence of the -863C>A polymorphism in the present study.
In summary, the TNF-α promoter alleles associated with higher plasma levels, i.e., All healthy controls had been tested previously for HLA-A, -B, -DRB1 (28). HLA-A, -B and HLA-DRB1 were genotyped serologically using PCR-sequence specific oligonucleotides or PCR-single strand conformational polymorphism technique.
Informed consent was obtained from each patient, and the Institutional Review Board of Human Research at Seoul National University Hospital approved the study protocol.
Genotyping of the SNPs in TNF-α promoter region
The seven SNPs in the TNF-α promoter region at positions -1031T>C, -863C>A, -857C>T, -376G>A, -308G>A, -238G>A, and -163G>A were genotyped by single-base extension methods (29) . The PCR primer sequences used for the amplification and extension of the TNF-α SNPs by the single-base extension methods are listed in Table   4 . PCR was performed in a mixture of 1.25 pmol of each primer, 50ng of genomic DNA, 250 µM dNTPs, and 0. Logistic regression models were used for calculating the odds ratios (95% confidential intervals) and corresponding P-values, controlling for age (continuous) and sex as covariates. In an analyzing model in which a codominant (additive) effect of the variant (V) allele was assumed, the genotypes Wild (W)/W, W/V, and V/V were coded as 0, 1, and 2, respectively; when a dominant effect was assumed, genotype W/W was coded as 0, and W/V and V/V combined were coded as 1. Accordingly, scores of 0 for W/W and W/V combined and of 1 for V/V were used in a model that assumed a recessive effect. Haplotypes with frequencies greater than 5% were used for analysis (Fig. 1B) . 
